LGMD2A clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 12-50
This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.
at UC Irvine
Our lead scientists for LGMD2A research studies include Tahseen Mozaffar, MD.